DGAP-News: Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose

DGAP-News: Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose

Related Keywords

Korneuburg ,Niederörreich ,Austria ,Australia ,Vienna ,Wien ,South Korea ,United Kingdom ,South Korean ,Austrian ,Lucia Mayr Harting ,Stephanie Kniep ,Pascal Schmidt ,Regina Lutz ,Shaun Brown ,Andreas Grassauer ,Brigitte Keller ,Cornelia Kutzer ,International Media Contact ,Mc Services ,Technologies Pty Ltd ,Funding Program ,Hanmi Pharmaceutical Co Ltd ,Vienna Stock Exchange ,Marinomed Biotech ,Chief Business Officer ,Aspen Pharmacare Australia ,Pty Ltd ,Convertible Notes Funding Program ,Show Participant Link ,